Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 3 Results

Title
Intervention Indication Therapeutic Area Year Actions
Inavolisib with palbociclib and fulvestrant for treating HR+/HER2-, PIK3CA mutated locally advanced or metastatic breast cancer Fulvestrant (Faslodex) , Inavolisib (GDC 0077;RG 6114) , Palbociclib (Ibrance; PD-0332991) Breast cancer Breast Cancer 2024 View  |  Download
Palbociclib for breast cancer - post neoadjuvant therapy Palbociclib (Ibrance; PD-0332991) Breast cancer Breast Cancer 2020 View  |  Download
Palbociclib with trastuzumab with or without pertuzumab and endocrine therapy for HR+/HER2+ metastatic breast cancer Palbociclib (Ibrance; PD-0332991) , Trastuzumab (Herceptin; RG-597) Breast cancer Breast Cancer 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications